S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

NCT00041067 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: trastuzumab
DRUG: docetaxel
DRUG: vinorelbine

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]